Cognitive behavioral therapy, clinical hypnosis, SSRIs/serotonin-norepinephrine reuptake inhibitors recommended based on level I evidence. In a position statement issued by the North American Menopause Society and published online June 1 in Menopause, updated recommendations are presented for the nonhormonal management of menopause-associated vasomotor symptoms. Chrisandra L. Shufelt, M.D., from the Mayo Clinic in Jacksonville, Florida, and...